mg-zg122
mAbexperimental
Clinical trial activity
2 trials · 2 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
1
Phase 3
0
Phase 4
0
Earliest trial started Dec 18, 2022 (NCT05659927)
Timeline
Indications
Studied for
Mechanism of action
- UnclearUnclear
Unclear unclear
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT07054034 | Phase 2 | May 11, 2025 | Shanghai Mabgeek Biotech.Co.Ltd |
| NCT05659927 | Phase 1 | Dec 18, 2022 | Anhui Medical University, Shanghai Mabgeek Biotech.Co.Ltd |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (2)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Shanghai Mabgeek Biotech.Co.Ltd | Academic/Hospital | 2 | 2 | 2 | 2022 |
| Anhui Medical University | Academic/Hospital | 1 | 0 | 1 | 2022 |
2 organizations
Page 1 / 1